Open contest
16 companies value 5.5 bn revenue 5.8 bn margin -7.7% free cash flow 0.3 bn avg. score 2.2
TRLV holds 36.3% of the group's value, 1.6x the runner-up · TLRY leads the industry without being the largest
| Rank | Ticker | Company | Share | Value | Revenue | Margin | FCF | 5 years | FCF/px | Yield | What it does · why it is here |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | TRLV | Trulieve Cannabis Corp. United States · score 4.0 | 36% | 2.0 bn | 1.1 bn | -10.2% | 0.2 bn | 10.1% | — | Medical and recreational cannabis · Florida — revenue of $1.1bn | |
| 2 | CRON | Cronos Group Inc. Canada · score 5.5 | 22% | 1.2 bn | 0.2 bn | 39.1% | 0.1 bn | 4.2% | 0.5% | Cannabinoids: research, technology and product development · Canada — revenue of $179m | |
| 3 | TLRY | Tilray Brands Canada · score 0.0 | 8% | 0.4 bn | 1.0 bn | -17.1% | -0.1 bn | -18.8% | — | Cannabis, craft beer and beverages · World's largest cannabis company by revenue, with beverages and medical products | |
| 4 | SNDL | SNDL Inc. Canada · score 4.0 | 6% | 0.3 bn | 0.7 bn | -1.7% | 0.0 bn | 12.5% | — | Cannabis retail and production in Canada · Canada — revenue of $674m | |
| 5 | VFF | Village Farms International, Inc. United States · score 2.7 | 6% | 0.3 bn | 0.2 bn | 9.8% | 0.0 bn | -0.1% | — | Greenhouse vegetables and cannabis, for three decades · Florida — revenue of $231m | |
| 6 | CGC | Canopy Growth Canada · score 0.0 | 6% | 0.3 bn | 0.2 bn | -79.2% | -0.1 bn | -19.6% | — | Medical and recreational cannabis, from Canada · Sector pioneer, with a historic investment from Constellation Brands | |
| 7 | HITI | High Tide Inc. Canada · score 3.3 | 4% | 0.2 bn | 0.4 bn | -8.7% | 0.0 bn | 4.3% | 0.4% | Chain of cannabis stores in Canada · Canada — revenue of $423m | |
| 8 | ACB | AURORA CANNABIS INC Canada · score 0.7 | 4% | 0.2 bn | 0.2 bn | -42.4% | -0.0 bn | -4.1% | — | Medical cannabis, from Canada · Canada — revenue of $228m | |
| 9 | GLAS | Glass House Brands Inc. United States · score 0.0 | 4% | 0.2 bn | 0.2 bn | -16.3% | -0.0 bn | -8.0% | — | Vertically integrated cannabis in California · California — revenue of $182m | |
| 10 | OGI | ORGANIGRAM GLOBAL INC. Canada · score 0.1 | 2% | 0.1 bn | 0.2 bn | -9.6% | -0.0 bn | -13.8% | — | Medical and recreational cannabis in Canada · Canada — revenue of $184m | |
| 11 | INCR | Intercure Ltd. Israel · score 3.3 | 1% | 0.1 bn | 0.1 bn | -13.6% | 0.0 bn | 6.4% | — | Medical cannabis, from Israel · Israel — revenue of $87m | |
| 12 | RYM | RYTHM, Inc. United States · score 2.1 | 1% | 0.0 bn | 0.1 bn | -6.2% | 0.0 bn | 3.6% | — | Hemp-derived THC products and licensed brands · Illinois — revenue of $51m | |
| 13 | IMCC | IM Cannabis Corp. Canada · score 0.0 | 0% | 0.0 bn | 0.0 bn | -40.6% | 0.0 bn | -17.8% | — | Import and sale of medical cannabis in Israel and Germany · Canada — revenue of $33m | |
| 14 | GTBIF | Green Thumb Industries United States · score 6.2 | — | — | 1.2 bn | 10.5% | 0.2 bn | — | — | Medical and recreational cannabis in the United States · The most profitable in the US sector; operates dispensaries in several states | |
| 15 | AKAN | AKANDA CORP. Canada · score 1.4 | — | — | 0.0 bn | — | -0.0 bn | — | — | Medical cannabis, from Canada · Canada | |
| 16 | EDVA | Endovia Health Sciences, Inc. United States · score 1.5 | — | — | 0.0 bn | — | -0.0 bn | — | — | Cannabinoid pharmaceuticals and wellness for people and animals, former beverage maker · Florida |
Other industries in the same sector
- Sector overview
- Large-cap pharmaceuticals 9 companies
- Biotechnology 57 companies
- European pharmaceuticals 5 companies
- Lab tools and consumables 37 companies
- Health insurance and services 17 companies
- Medical devices 87 companies
- Specialty pharmaceuticals 77 companies
- Pharmaceutical distribution 7 companies
- Clinical-stage pharmaceuticals 251 companies
- Robotic surgery and advanced medtech 9 companies
- Hospitals 23 companies
- Emerging biotech 5 companies
and 22 industries more
- Molecular testing and advanced diagnostics 42 companies
- Vaccines and mRNA 14 companies
- Clinical-stage biotech 200 companies
- Generics and biosimilars 10 companies
- Animal health 7 companies
- Contract research (CRO) 10 companies
- Consumer health (OTC) 4 companies
- Healthcare software 18 companies
- Rehabilitation and home care 15 companies
- Genomics and sequencing 9 companies
- Structural heart 8 companies
- Ophthalmology 12 companies
- Medical imaging and hospital equipment 16 companies
- Diagnostic labs 6 companies
- Medical and dental supply distribution 3 companies
- Diabetes monitoring 9 companies
- Pharmaceutical royalties 5 companies
- Respiratory and sleep therapy 9 companies
- Orthopedic implants 17 companies
- Dialysis 3 companies
- Telehealth and digital health 12 companies
- Dental 4 companies
What this is. A catalogue, not a guide. Every industry with stocks listed on the NYSE or NASDAQ, the companies contending for its leadership, what each one does according to its own annual report, and the balance sheet it filed with the SEC.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.
The score runs from 0 to 10 and compares each company with every other one in the almanac on cash generation, profitability, debt, dividends and consistency over the last five years. The higher it is, the better the company fares in that comparison. Curious how much each part weighs? Ask at the bottom of the page.